Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aquamin® for Gastrointestinal Permeability in UC, IBS-D, and Healthy Individuals
NCT04855799Phase 2Completed
- Start
- Nov 2021
- Primary completion
- Mar 2024
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial. Primary endpoints: Change in the Lactulose:Mannitol Ratio in Urine at 90 days and Mannitol Levels in Urine Samples at 90 days. Started Nov 2021; status: completed.
Beyond the preview
Go deeper on NCT04855799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04855799.